Edition:
United States

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

94.75SEK
18 Dec 2017
Change (% chg)

0.25kr (+0.26%)
Prev Close
94.50kr
Open
95.00kr
Day's High
95.00kr
Day's Low
92.00kr
Volume
42,415
Avg. Vol
18,433
52-wk High
108.00kr
52-wk Low
78.25kr

Chart for

About

Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO... (more)

Overall

Beta: 0.48
Market Cap(Mil.): kr2,475.00
Shares Outstanding(Mil.): 26.19
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 60.10 16.04
EPS (TTM): -- -- --
ROI: -- 13.32 34.69
ROE: -- 19.86 15.46

BRIEF-Xvivo Q3 EBITDA ex-items at SEK 4.4 million

* Q3 NET SALES SEK ‍32.3​ MILLION VERSUS SEK 31.7 MILLION YEAR AGO

Oct 27 2017

BRIEF-Xvivo Perfusion's CFO Christoffer Rosenblad appointed deputy CEO

* ‍CFO CHRISTOFFER ROSENBLAD HAS BEEN APPOINTED DEPUTY CEO WITH EFFECT FROM JULY 17, 2017​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jul 17 2017

BRIEF-Xvivo Perfusion Q2 EBITDA ex-items down at SEK ‍6.2​ mln

* Q2 EBITDA EX-ITEMS SEK ‍6.2​ MILLION VERSUS SEK 6.9 MILLION YEAR AGO

Jul 14 2017

Earnings vs. Estimates